Screener
Janux Therapeutics JANX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's total equity?
- Janux Therapeutics (JANX) reported total equity of $927.98M in Q2 2026.
- How has Janux Therapeutics's total equity changed year-over-year?
- Janux Therapeutics's total equity decreased by 6.3% year-over-year, from $990.52M to $927.98M.
- What is the long-term trend for Janux Therapeutics's total equity?
- Over 5 years (2020 to 2025), Janux Therapeutics's total equity has grown at a 130.7% compound annual growth rate (CAGR), from -$14.64M to $956.82M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Janux Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude